http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrentP6Yhttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate201911Memberhttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrentQ1http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNetfalsehttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrentP30Dhttp://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet--12-31http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrentP20Dhttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent0001719489http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrent0001719489us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310001719489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-03-310001719489us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001719489klr:EuropeExcludingItalyMember2023-01-012023-03-310001719489us-gaap:CommonStockMember2023-01-012023-03-3100017194892022-12-310001719489us-gaap:CommonStockMember2021-12-310001719489klr:MGageMemberklr:PIPESubscriptionAgreementsMember2021-02-182021-02-180001719489us-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489us-gaap:CommonStockMember2022-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:NonUsMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310001719489klr:MonteDeiPaschiDiSienaSPALine2Member2022-12-310001719489us-gaap:RetainedEarningsMember2022-12-310001719489klr:OtherCountriesMember2022-01-012022-03-310001719489us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310001719489country:US2023-01-012023-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembersrt:SouthAmericaMember2023-01-012023-03-310001719489us-gaap:WarrantMember2023-01-012023-03-310001719489srt:MaximumMember2022-01-012022-12-310001719489us-gaap:AccountingStandardsUpdate201613Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2023-03-310001719489us-gaap:WarrantMember2022-01-012022-09-300001719489klr:KaleyraSPAMemberklr:PietroCalogeroMember2023-01-012023-03-310001719489klr:MonteDeiPaschiDiSienaSPALine2Member2023-03-310001719489srt:MaximumMember2023-01-012023-03-310001719489us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489klr:GeneralUnsecuredLoanAgreementMemberklr:FundForIntegratedPromotionMember2021-09-150001719489klr:IntesaSanPaoloSPALineFourMember2022-12-3100017194892022-01-012022-12-310001719489us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001719489klr:SimestFourMember2022-12-310001719489klr:BandyerSrlMember2021-07-082021-07-080001719489us-gaap:CertificatesOfDepositMember2023-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2023-01-012023-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberstpr:IN2022-01-012022-03-310001719489klr:BancoPopolareSPAMemberklr:NewUnsecuredLoanAgreementMember2022-07-280001719489us-gaap:RestrictedStockUnitsRSUMember2023-03-310001719489klr:GeneralUnsecuredLoanAgreementMemberklr:FundForIntegratedPromotionMember2021-04-150001719489us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489us-gaap:AccountingStandardsUpdate201613Member2023-03-310001719489klr:SimestTwoMember2023-01-012023-03-310001719489us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310001719489klr:BandyerSrlMember2022-01-012022-03-310001719489klr:NonCurrentAssetsMemberus-gaap:GeographicConcentrationRiskMembercountry:IT2022-01-012022-12-310001719489us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-03-310001719489us-gaap:MutualFundMember2022-12-310001719489klr:IntesaSanPaoloSPALineThreeMember2023-01-012023-03-310001719489us-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489klr:SimestOneMember2023-01-012023-03-3100017194892022-01-012022-03-310001719489us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489klr:ConvertibleNotesMemberklr:WilmingtonTrustNationalAssociationMember2023-03-310001719489us-gaap:RetainedEarningsMember2022-03-310001719489country:IT2022-12-3100017194892021-12-310001719489klr:BancoBPMSPALineOneMember2023-01-012023-03-310001719489klr:SimestOneMember2022-12-310001719489us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001719489klr:BancoBPMSPALineOneMember2023-03-310001719489klr:MGageMember2021-08-300001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberklr:OtherCountriesMember2023-01-012023-03-310001719489klr:MGageMember2021-02-182021-02-180001719489klr:OtherCountriesMember2022-12-310001719489us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMember2022-12-310001719489klr:WarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-3100017194892022-03-310001719489us-gaap:GeographicConcentrationRiskMemberklr:NonCurrentAssetsMembercountry:IT2023-01-012023-03-310001719489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310001719489klr:UnicreditSPALineATrancheTwoMember2022-12-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberstpr:IN2023-01-012023-03-310001719489klr:MonteDeiPaschiDiSienaSPALine2Member2023-01-012023-03-310001719489us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2023-03-310001719489us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310001719489us-gaap:RetainedEarningsMember2023-03-310001719489country:IT2023-01-012023-03-310001719489country:US2023-03-310001719489klr:KaleyraUSIncorporationMember2021-11-150001719489us-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489klr:IntesaSanPaoloSPALineTwoMember2022-12-310001719489klr:SimestTwoMember2023-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:IT2022-01-012022-03-310001719489us-gaap:DevelopedTechnologyRightsMember2022-12-310001719489klr:UnicreditSPALineCMember2022-12-310001719489klr:ChardanMember2023-03-310001719489us-gaap:CertificatesOfDepositMember2022-12-310001719489klr:NonCurrentAssetsMemberus-gaap:GeographicConcentrationRiskMemberklr:OtherCountriesMember2022-01-012022-12-310001719489us-gaap:AdditionalPaidInCapitalMember2021-12-310001719489klr:IntesaSanPaoloSPALineTwoMember2023-03-310001719489klr:ChardanMemberus-gaap:OtherCurrentLiabilitiesMember2023-03-310001719489us-gaap:CustomerRelationshipsMember2022-12-310001719489klr:BancoBPMSPALineFourMember2023-03-310001719489klr:Fund39481Memberklr:GeneralUnsecuredLoanAgreementMember2021-04-150001719489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310001719489us-gaap:GeographicConcentrationRiskMemberklr:NonCurrentAssetsMemberstpr:IN2023-01-012023-03-310001719489srt:SouthAmericaMember2023-01-012023-03-310001719489klr:ConvertibleNotesMember2021-06-010001719489us-gaap:RetainedEarningsMember2021-12-310001719489us-gaap:MutualFundMember2023-03-310001719489stpr:IN2023-03-310001719489us-gaap:PatentsMember2022-12-310001719489us-gaap:WarrantMember2023-03-3100017194892023-01-012023-03-310001719489klr:ConvertibleNotesMemberklr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMemberklr:ResaleRegistrationStatementMember2020-04-162020-04-160001719489srt:MinimumMember2023-01-010001719489us-gaap:AccountingStandardsUpdate201613Member2023-01-012023-03-310001719489us-gaap:TreasuryStockMember2022-12-310001719489us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SellingAndMarketingExpenseMember2022-01-012022-03-310001719489klr:UnicreditSPALineATrancheTwoMember2023-01-012023-03-310001719489klr:CowenInvestmentsMember2021-02-042021-02-040001719489us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-03-310001719489klr:SimestFourMember2023-01-012023-03-310001719489klr:MGageMember2021-06-010001719489klr:UnicreditSPALineBMember2023-01-012023-03-310001719489klr:CustomersMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001719489klr:UnicreditSPALineCMember2023-03-310001719489klr:KaleyraSPAMemberklr:PietroCalogeroMember2022-01-012022-03-3100017194892023-03-0600017194892023-05-050001719489us-gaap:WarrantMember2023-01-012023-03-310001719489klr:SimestFourMember2023-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:IT2023-01-012023-03-310001719489us-gaap:RestrictedStockUnitsRSUMember2022-12-310001719489us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310001719489us-gaap:TreasuryStockMember2022-03-310001719489us-gaap:TradeNamesMember2023-03-310001719489us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489klr:SimestThreeMember2022-12-310001719489srt:MinimumMember2022-01-012022-12-310001719489us-gaap:CustomerRelationshipsMember2023-03-310001719489klr:IntesaSanPaoloSPALineFourMember2023-03-310001719489us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001719489us-gaap:DevelopedTechnologyRightsMember2023-03-310001719489klr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMember2020-04-162020-04-160001719489klr:ConvertibleNotesMember2023-03-310001719489us-gaap:CommonStockMember2023-03-062023-03-060001719489us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489klr:ChardanMember2020-05-010001719489stpr:IN2023-01-012023-03-310001719489klr:CustomersMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001719489us-gaap:CommonStockMember2023-01-012023-03-310001719489klr:ChardanMemberus-gaap:SubsequentEventMember2023-05-010001719489us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489country:US2022-12-310001719489klr:UnicreditSPALineBMember2022-12-310001719489us-gaap:GeographicConcentrationRiskMemberklr:EuropeExcludingItalyMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-03-310001719489us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489klr:SimestOneMember2023-03-310001719489us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489us-gaap:PatentsMember2023-03-310001719489klr:UnicreditSPALineATrancheOneMember2023-03-310001719489srt:MaximumMemberus-gaap:SubsequentEventMember2023-04-030001719489country:IT2022-01-012022-03-310001719489us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembersrt:SouthAmericaMember2022-01-012022-03-310001719489us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001719489klr:LynrockLakeLpMembersrt:MinimumMember2023-01-012023-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2022-01-012022-03-310001719489us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001719489us-gaap:TradeNamesMember2022-12-310001719489us-gaap:WarrantMember2023-03-080001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberklr:OtherCountriesMember2022-01-012022-03-310001719489country:IT2023-03-310001719489country:US2022-01-012022-03-310001719489us-gaap:AdditionalPaidInCapitalMember2023-03-310001719489us-gaap:AdditionalPaidInCapitalMember2022-03-310001719489us-gaap:AdditionalPaidInCapitalMember2022-12-3100017194892023-01-010001719489us-gaap:GeographicConcentrationRiskMemberklr:NonCurrentAssetsMemberklr:OtherCountriesMember2023-01-012023-03-310001719489us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489klr:SimestThreeMember2023-01-012023-03-310001719489klr:UnicreditSPALineATrancheOneMember2022-12-310001719489us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310001719489us-gaap:RetainedEarningsMember2022-01-012022-03-310001719489klr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMemberklr:ResaleRegistrationStatementMember2020-04-162020-04-160001719489klr:SimestTwoMember2022-12-310001719489klr:CowenInvestmentsMember2020-05-012020-05-010001719489klr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMemberklr:ResaleRegistrationStatementMember2020-04-1600017194892023-03-310001719489klr:WarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489klr:ConvertibleNotesMember2023-01-012023-03-310001719489us-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489us-gaap:FairValueInputsLevel2Memberklr:WarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489klr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2023-01-012023-03-310001719489klr:NonCurrentAssetsMemberus-gaap:GeographicConcentrationRiskMembercountry:US2022-01-012022-12-310001719489us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMember2023-03-310001719489us-gaap:TreasuryStockMember2021-12-310001719489klr:IntesaSanPaoloSPALineThreeMember2022-12-310001719489klr:IntesaSanPaoloSPALineFourMember2023-01-012023-03-310001719489stpr:IN2022-12-310001719489us-gaap:AccountingStandardsUpdate201613Member2022-12-310001719489klr:ConvertibleNotesMember2023-03-090001719489klr:MGageMember2021-08-302021-08-300001719489us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-01-012023-03-310001719489klr:UnicreditSPALineATrancheOneMember2023-01-012023-03-310001719489klr:GeneralUnsecuredLoanAgreementMember2021-04-152021-04-150001719489klr:BancoBPMSPALineOneMember2022-12-310001719489us-gaap:TreasuryStockMember2023-03-310001719489us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SellingAndMarketingExpenseMember2023-01-012023-03-310001719489us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310001719489us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-3100017194892022-09-300001719489srt:MaximumMember2023-03-310001719489us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001719489klr:UnicreditSPALineBMember2023-03-310001719489klr:BancoBPMSPALineThreeMember2023-01-012023-03-310001719489klr:ConvertibleNotesMemberklr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMemberklr:ResaleRegistrationStatementMember2020-04-160001719489us-gaap:RestrictedStockUnitsRSUMember2022-12-300001719489klr:FinancialIncomeExpenseMemberus-gaap:InterestRateSwapMember2023-01-012023-03-310001719489country:IN2023-03-310001719489klr:IntesaSanPaoloSPALineTwoMember2023-01-012023-03-310001719489klr:IntesaSanPaoloSPALineThreeMember2023-03-310001719489klr:OtherCountriesMember2023-01-012023-03-310001719489klr:MGageMember2021-06-012021-06-010001719489klr:EuropeExcludingItalyMember2022-01-012022-03-310001719489us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001719489srt:MinimumMember2023-01-012023-03-310001719489us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001719489klr:BancoBPMSPALineFourMember2022-12-310001719489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001719489stpr:IN2022-01-012022-03-310001719489us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-03-310001719489klr:BancoBPMSPALineThreeMember2022-12-310001719489srt:MaximumMember2022-11-070001719489us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-12-310001719489klr:CowenInvestmentsMember2021-02-040001719489us-gaap:GeographicConcentrationRiskMemberklr:NonCurrentAssetsMembercountry:US2023-01-012023-03-310001719489srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-12-310001719489klr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2022-01-012022-12-310001719489us-gaap:FairValueInputsLevel2Memberklr:WarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489us-gaap:GeographicConcentrationRiskMemberklr:NonCurrentAssetsMemberstpr:IN2022-01-012022-12-310001719489srt:SouthAmericaMember2022-01-012022-03-310001719489us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310001719489us-gaap:CommonStockMember2022-01-012022-03-310001719489klr:MGageSADeSVMember2021-07-010001719489klr:ConvertibleNotesMember2023-03-092023-03-090001719489klr:CowenInvestmentsAndChardanMember2020-05-010001719489us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001719489us-gaap:MutualFundMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001719489us-gaap:CommonStockMember2023-03-060001719489us-gaap:RetainedEarningsMember2023-01-012023-03-310001719489us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001719489us-gaap:InterestRateSwapMember2023-03-310001719489klr:ConvertibleNotesMemberklr:SecondAnniversaryMember2023-01-012023-03-310001719489us-gaap:InterestRateSwapMember2022-12-310001719489klr:SimestThreeMember2023-03-310001719489klr:OtherCountriesMember2023-03-310001719489us-gaap:SellingAndMarketingExpenseMember2022-01-012022-03-310001719489klr:KaleyraIncorporationMember2021-11-150001719489klr:UnicreditSPALineATrancheTwoMember2023-03-310001719489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001719489klr:GeneralUnsecuredLoanAgreementMember2023-01-012023-03-310001719489us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberklr:EuropeExcludingItalyMember2023-01-012023-03-310001719489klr:GeneralUnsecuredLoanAgreementMemberklr:SimestSPAMember2021-04-150001719489klr:BancoBPMSPALineFourMember2023-01-012023-03-310001719489us-gaap:CommonStockMember2023-03-310001719489klr:ChardanMember2020-05-012020-05-010001719489us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2022-12-310001719489klr:MGageMemberklr:PIPESubscriptionAgreementsMember2021-02-180001719489klr:FinancialIncomeExpenseMemberus-gaap:InterestRateSwapMember2022-01-012022-03-310001719489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-03-310001719489klr:BancoBPMSPALineThreeMember2023-03-310001719489us-gaap:MutualFundMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001719489klr:UnicreditSPALineCMember2023-01-012023-03-3100017194892020-05-010001719489us-gaap:WarrantMember2023-03-090001719489us-gaap:CommonStockMember2022-12-310001719489klr:CowenInvestmentsMember2020-05-010001719489klr:Fund39481Memberklr:GeneralUnsecuredLoanAgreementMember2021-09-150001719489klr:BancoPopolareSPAMemberklr:EuriborMemberklr:NewUnsecuredLoanAgreementMember2022-07-282022-07-280001719489us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-31iso4217:EURxbrli:purexbrli:sharesklr:PerformanceObligationiso4217:USDxbrli:sharesutr:Diso4217:USDklr:Customer

 

al

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-38320

 

KALEYRA, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

82-3027430

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification Number)

 

85 Broad Street, New York, NY

10004

(Address of principal executive offices)

(Zip Code)

 

Registrant’s telephone number, including area code: +1 917 508 9185

(Former name or former address, if changed since last report): N/A

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbols

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

KLR

New York Stock Exchange

Warrants, at an exercise price of $40.25 per share of Common Stock

KLR WS

NYSE American LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

 

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of May 5, 2023, there were 13,198,795 shares of the Company’s common stock issued and outstanding.

 

 


 

KALEYRA, INC.

Quarterly Report on Form 10-Q

Table of Contents

PART I – FINANCIAL INFORMATION

Page

 

Item 1.

Condensed Consolidated Financial Statements (unaudited):

1

 

Condensed Consolidated Balance Sheets

1

 

Condensed Consolidated Statements of Operations

2

 

 

Condensed Consolidated Statements of Comprehensive Loss

3

 

 

 

 

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

4

 

 

 

Condensed Consolidated Statements of Cash Flows

5

 

Notes to Condensed Consolidated Financial Statements

6

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

27

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

38

 

Item 4.

Controls and Procedures

39

 

PART II – OTHER INFORMATION

 

 

Item 1.

Legal Proceedings

40

 

Item 1A.

Risk Factors

42

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

42

 

Item 3.

Defaults Upon Senior Securities

42

 

Item 4.

Mine Safety Disclosures

42

 

Item 5.

Other Information

42

 

Item 6.

Exhibits

43

 

Signatures

44

 

 


 

Item 1 – Financial Statements

KALEYRA, INC.

Condensed Consolidated Balance Sheets

(Unaudited, in thousands, except share and per share data)

 

 

 

March 31, 2023

 

 

December 31, 2022

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

74,362

 

 

$

77,500

 

Restricted cash

 

 

488

 

 

 

480

 

Short-term investments

 

 

637

 

 

 

587

 

Trade receivables, net

 

 

82,948

 

 

 

86,783

 

Deferred cost

 

 

334

 

 

 

319

 

Prepaid expenses

 

 

3,764

 

 

 

3,989

 

Other current assets

 

 

3,944

 

 

 

3,387

 

Total current assets

 

 

166,477

 

 

 

173,045

 

Property and equipment, net

 

 

23,840

 

 

 

23,826

 

Operating right-of-use assets

 

 

2,781

 

 

 

2,931

 

Intangible assets, net

 

 

55,229

 

 

 

57,400

 

Goodwill

 

 

111,801

 

 

 

111,526

 

Deferred tax assets

 

 

 

 

 

 

Other long-term assets

 

 

1,995

 

 

 

1,445

 

Total Assets

 

$

362,123

 

 

$

370,173

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

80,331

 

 

$

82,258

 

Lines of credit

 

 

2,991

 

 

 

3,955

 

Current portion of notes payable

 

 

405

 

 

 

405

 

Current portion of bank and other borrowings

 

 

10,234

 

 

 

11,419

 

Deferred revenue

 

 

3,290

 

 

 

3,528

 

Payroll and payroll related accrued liabilities

 

 

7,371

 

 

 

5,993

 

Other current liabilities

 

 

14,502

 

 

 

9,431

 

Total current liabilities

 

 

119,124

 

 

 

116,989

 

Long-term portion of bank and other borrowings

 

 

11,675

 

 

 

13,459

 

Long-term portion of notes payable

 

 

192,293

 

 

 

191,777

 

Long-term portion of employee benefit obligation

 

 

2,359

 

 

 

2,373

 

Deferred tax liabilities

 

 

 

 

 

 

Other long-term liabilities

 

 

3,052

 

 

 

3,362

 

Total Liabilities

 

 

328,503

 

 

 

327,960

 

Commitments and contingencies (Note 14)

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; no shares issued or outstanding

 

 

 

 

 

 

Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 13,998,241 shares issued and 13,198,795 shares outstanding as of March 31, 2023 and 13,858,440 shares issued and 13,058,994 shares outstanding as of December 31, 2022

 

 

1

 

 

 

1

 

Additional paid-in capital

 

 

280,486

 

 

 

278,473

 

Treasury stock, at cost; 799,446 shares as of March 31, 2023 and December 31, 2022

 

 

(30,431

)

 

 

(30,431

)

Accumulated other comprehensive loss

 

 

(4,584

)

 

 

(5,212

)

Accumulated deficit

 

 

(211,852

)

 

 

(200,618

)

Total stockholders’ equity

 

 

33,620

 

 

 

42,213

 

Total liabilities and stockholders’ equity

 

$

362,123

 

 

$

370,173

 

__________________

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

1


 

KALEYRA, INC.

Condensed Consolidated Statements of Operations

(Unaudited, in thousands, except share and per share data)

 

 

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

Revenue

 

$

83,618

 

 

$

80,481

 

Cost of revenue

 

 

62,518

 

 

 

62,743

 

Gross profit

 

 

21,100

 

 

 

17,738

 

Operating expenses:

 

 

 

 

 

 

Research and development

 

 

5,402

 

 

 

4,890

 

Sales and marketing

 

 

6,014

 

 

 

7,100

 

General and administrative

 

 

14,036

 

 

 

15,380

 

Total operating expenses

 

 

25,452

 

 

 

27,370

 

Loss from operations

 

 

(4,352

)

 

 

(9,632

)

Other income, net

 

 

15

 

 

 

46

 

Financial expense, net

 

 

(3,634

)

 

 

(3,152

)

Foreign currency income (loss)

 

 

(969

)

 

 

257

 

Loss before income tax expense

 

 

(8,940

)

 

 

(12,481

)

Income tax expense

 

 

1,024

 

 

 

691

 

Net loss

 

$

(9,964

)

 

$

(13,172

)

Net loss per common share, basic and diluted

 

$

(0.76

)

 

$

(1.09

)

Weighted-average shares used in computing net loss per common share, basic and diluted

 

 

13,044,570

 

 

 

12,070,720

 

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


 

KALEYRA, INC.

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited, in thousands)

 

 

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

Net loss

 

$

(9,964

)

 

$

(13,172

)

Other comprehensive income (loss):

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

620

 

 

 

(634

)

Net change in unrealized gain on marketable securities, net of tax

 

 

8

 

 

 

5

 

Total other comprehensive income (loss)

 

 

628

 

 

 

(629

)

Total comprehensive loss

 

$

(9,336

)

 

$

(13,801

)

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3


 

KALEYRA, INC.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(Unaudited, in thousands, except share data)

 

 

 

Three Months Ended March 31, 2023

 

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Treasury Stock

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

Total
Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Income (Loss)

 

 

Deficit

 

 

Equity

 

Balance as of December 31, 2022 (1)

 

 

13,858,440

 

 

$

1

 

 

$

278,473

 

 

 

799,446

 

 

$

(30,431

)

 

$

(5,212

)

 

$

(200,618

)

 

$

42,213

 

Adoption of ASC 326

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,270

)

 

 

(1,270

)

Stock-based compensation (RSUs)

 

 

139,801

 

 

 

 

 

 

2,013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,013

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9,964

)

 

 

(9,964

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

628

 

 

 

 

 

 

628

 

Balance as of March 31, 2023

 

 

13,998,241

 

 

$

1

 

 

$

280,486

 

 

 

799,446

 

 

$

(30,431

)

 

$

(4,584

)

 

$

(211,852

)

 

$

33,620

 

 

 

 

 

Three Months Ended March 31, 2022

 

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Treasury Stock

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

Total
Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Income (Loss)

 

 

Deficit

 

 

Equity

 

Balance as of December 31, 2021 (1)

 

 

12,908,327

 

 

$

1

 

 

$

251,662

 

 

 

799,446

 

 

$

(30,431

)

 

$

(2,010

)

 

$

(101,800

)

 

$

117,422

 

Stock-based compensation (RSUs)

 

 

93,770

 

 

 

 

 

 

6,759

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,759

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(13,172

)

 

 

(13,172

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(629

)

 

 

 

 

 

(629

)

Balance as of March 31, 2022 (1)

 

 

13,002,097

 

 

$

1

 

 

$

258,421

 

 

 

799,446

 

 

$

(30,431

)

 

$

(2,639

)

 

$

(114,972

)

 

$

110,380

 

____________________

(1)
Amounts as of December 31, 2022 and before that date differ from those published in the Company's prior consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (as described below in Note 1 - Description of Organization and Business Operations). Specifically, the number of shares of common stock outstanding during periods before the Reverse Stock Split were divided by the split ratio of 3.5:1, such that each 3.5 shares of common stock were combined and reconstituted into one share of common stock effective March 9, 2023.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


 

KALEYRA, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited, in thousands)

 

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

Net loss

 

$

(9,964

)

 

$

(13,172

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

4,435

 

 

 

5,902

 

Stock-based compensation

 

 

2,013

 

 

 

6,759

 

Non-cash reduction to the right-of-use asset

 

 

10

 

 

 

 

Provision for doubtful accounts

 

 

2,503

 

 

 

176

 

Realized gains on marketable securities

 

 

8

 

 

 

5

 

Employee benefit obligation

 

 

144

 

 

 

514

 

Change in fair value of warrant liability

 

 

12

 

 

 

(534

)

Non-cash interest expense

 

 

528

 

 

 

490

 

Deferred taxes

 

 

 

 

 

820

 

Change in operating assets and liabilities:

 

 

 

 

 

 

Trade receivables

 

 

481

 

 

 

3,010

 

Other current assets

 

 

(275

)

 

 

1,504

 

Deferred cost

 

 

(15

)

 

 

22

 

Operating lease liability

 

 

3

 

 

 

 

Other long-term assets

 

 

(542

)

 

 

(1,074

)

Accounts payable

 

 

(2,614

)

 

 

(816

)

Other current liabilities

 

 

6,399

 

 

 

2,334

 

Deferred revenue

 

 

(276

)

 

 

(2,708

)

Long-term liabilities

 

 

(397

)

 

 

(40

)

Net cash provided by operating activities

 

 

2,453

 

 

 

3,192

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

Purchase of short-term investments

 

 

(46

)

 

 

(1,165

)

Purchase of property and equipment

 

 

(231

)

 

 

(544

)

Capitalized software development costs

 

 

(1,806

)

 

 

(2,332

)

Acquisition of Bandyer, net of cash acquired

 

 

 

 

 

58

 

Net cash used in investing activities

 

 

(2,083

)

 

 

(3,983

)

Cash Flows from Financing Activities:

 

 

 

 

 

 

Proceeds from (repayments on) line of credit, net

 

 

(1,014

)

 

 

(525

)

Repayments on term loans

 

 

(3,340

)

 

 

(2,134

)

Repayments on capital lease

 

 

(48

)

 

 

(29

)

Net cash used in financing activities

 

 

(4,402

)

 

 

(2,688

)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

902

 

 

 

(334

)

Net decrease in cash, cash equivalents and restricted cash

 

 

(3,130

)

 

 

(3,813

)

Cash, cash equivalents and restricted cash, beginning of period (1)

 

 

77,980

 

 

 

91,702

 

Cash, cash equivalents and restricted cash, end of period (1)

 

$

74,850

 

 

$

87,889

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

 

Cash paid for interest

 

$

351

 

 

$

173

 

Non-cash investing and financing activities

 

 

 

 

 

 

Consideration payable

 

$

488

 

 

$

480

 

Adoption of ASC 326

 

$

(1,270

)

 

$

 

______________________

(1)
As of March 31, 2023, includes $74.4 million of cash and cash equivalents and $488,000 of restricted cash; as of December 31, 2022, includes $77.5 million of cash and cash equivalents and $480,000 of restricted cash.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

5


 

KALEYRA, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Kaleyra, Inc., formerly GigCapital, Inc., (hereinafter “Kaleyra” or the “Company”), was incorporated in Delaware on October 9, 2017. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

On February 22, 2019, the Company entered into a stock purchase agreement (the “Stock Purchase Agreement”) by and among the Company, Kaleyra S.p.A., Shareholder Representative Services LLC (the “Seller Representative”), as representative for the holders of the ordinary shares of Kaleyra S.p.A. immediately prior to the closing of the business combination with Kaleyra (the “Business Combination”), and all of the stockholders of all of the Kaleyra S.p.A. stock (collectively, such Kaleyra S.p.A. stockholders, the “Sellers”), for the purpose of the Company acquiring all of the shares of Kaleyra S.p.A.

As a result of the Business Combination, which closed on November 25, 2019, the Company (headquartered in Milan, Italy) became a multi-channel integrated communications services provider on a global scale. At the time of the closing of the Business Combination, Kaleyra operated in the Communications Platform as a Service (“CPaaS”) market with operations primarily in Italy, India, Dubai and the United States. In connection with the closing, the Company changed its name from GigCapital, Inc. to Kaleyra, Inc.

Kaleyra provides mobile communications services to financial institutions, e-commerce players, OTTs, software companies, logistic enablers, healthcare providers, retailers, and other large organizations worldwide. Through its proprietary cloud communications platforms (collectively, the “Platforms”), Kaleyra manages multi-channel integrated communications services on a global scale, consisting of inbound/outbound messaging solutions, programmable voice and Interactive Voice Response (IVR) configurations, hosted telephone numbers, conversational marketing solutions, RCS, and other types of IP communications services such as e-mail, push notifications, video/audio/chat, and WhatsApp®.

On October 22, 2019, Kaleyra’s U.S. subsidiary, The Campaign Registry Inc. (“TCR”), was incorporated under the laws of Delaware to promote a systems initiative to reduce spam by collecting robotically driven campaign information and processing and sharing that information with mobile operators and the messaging ecosystem. TCR started to account for its first revenue in the second half of fiscal year 2020 and revenue has constantly increased since then. On March 26, 2021, a wholly owned subsidiary of TCR was incorporated under the laws of Canada, with the registered office in Vancouver, British Columbia. This new subsidiary was established with the goal to further expand the registry legacy business in North America.

On July 29, 2020, Kaleyra registered a German branch of Kaleyra S.p.A. with the German Chamber Tax Authority of Commerce. Kaleyra established its branch in Germany to expand Kaleyra’s footprint in Central Europe and the Nordic countries and allow it to leverage Kaleyra’s trusted business solutions for customers in additional jurisdictions.

On February 18, 2021, Kaleyra entered into an agreement and plan of merger (the “Merger Agreement”) with Vivial, Inc. (“Vivial”) for the acquisition of the business known as mGage (“mGage”), a leading global mobile messaging provider in the United States (the transaction contemplated by the Merger Agreement, the “Merger”).

On June 1, 2021, Kaleyra completed its acquisition of mGage for a total purchase price of $218.0 million. The Merger consideration consisted of both cash consideration and common stock consideration. On August 30, 2021, the Company prepared and delivered to the Stockholder Representative a written statement (the “Post-Closing Statement”) setting forth the calculation of closing cash and closing net working capital which ultimately resulted in the final Merger consideration to be equal to $217.0 million pursuant to the terms of the Merger Agreement. The cash consideration amounted to $199.2 million of which $198.6 million was paid on June 1, 2021 and the remaining amount was settled during the period ended September 30, 2021, including a working capital adjustment of $997,000. The common stock consideration was paid with the issuance to Vivial’s former equity holders of a total of 457,143 shares of Kaleyra common stock at the $41.20 per share closing price of Kaleyra common stock on the date of issuance, equal to $18.8 million (on a post-reverse split basis). In support of the consummation of the Merger, on February 18, 2021, Kaleyra entered into subscription agreements (the “PIPE Subscription Agreements”), with certain institutional investors (the “PIPE Investors”), pursuant to which, among other things, Kaleyra agreed to issue and sell, in private placements to close immediately prior to the closing of the Merger, an aggregate of 2,400,000 shares of Kaleyra common stock to the PIPE Investors at $43.75 per share (on a post-reverse split basis). Kaleyra also entered into convertible note subscription agreements (the “Convertible Note Subscription Agreements”) with certain institutional investors (the “Convertible Note Investors”), pursuant to which Kaleyra agreed to issue and sell, in private placements to close immediately prior to the closing of the Merger, $200 million aggregate principal amount of unsecured convertible notes (the “Merger Convertible Notes”).

On July 1, 2021, Kaleyra completed a company reorganization of the acquired business of mGage through the initial dissolution of the Delaware single member LLCs of Vivial Holdings, LLC, Vivial Networks, LLC, and the following merger of mGage, LLC into

6


 

the surviving holding company, Vivial Inc., which subsequently changed its name into Kaleyra US Inc., as a result of the reorganization. As a result of the merger, Kaleyra US Inc. became the holding company and one hundred percent (100%) owner of Kaleyra UK Limited – previously known as mGage Europe Ltd. (UK) and mGage SA de SV (Mexico).
 

On July 8, 2021, Kaleyra completed the acquisition of Bandyer Srl (“Bandyer”) for cash consideration of $15.4 million. Bandyer offers cloud-based audio/video communications services via Web Real Time Communication (“WebRTC”) technology to financial institutions, retail companies, utilities, industries, insurance companies, human resources, and digital healthcare organizations. Bandyer provides customers with programmable audio/video APIs and Software Development Kits (“SDKs”) based on WebRTC technology for a variety of use cases, including Augmented Reality (“AR”) applications for smart glasses.
 

Effective August 31, 2021, the common stock of the Company ceased trading on the NYSE American and commenced trading on the NYSE under the ticker symbol “KLR”. Kaleyra’s warrants continue to trade on the NYSE American under the symbol “KLR WS”.

On October 11, 2021, Kaleyra Africa Ltd, a wholly owned subsidiary of Kaleyra Inc., was incorporated under the laws of South Africa with the registered office in Waterfall City, Gauteng. This newly established subsidiary is part of Kaleyra's broader strategic plan of expanding into emerging markets whereby South Africa will serve as Kaleyra's hub to enter the entire African market.

On November 15, 2021, pursuant to the provisions of the Merger Agreement, Kaleyra Dominicana, S.R.L., the ninety-nine percent (99%) direct owner of Kaleyra US Inc. and one percent (1%) direct owner of Kaleyra Inc., was incorporated under the laws of the Dominican Republic with the registered office in Santo Domingo. This newly established subsidiary is aimed to provide the Kaleyra group with back-office technology support and engage in product development and innovation.

On January 13, 2022, Kaleyra completed a company reorganization of the acquired business of Bandyer by means of the merger of the Italian legal entity of Bandyer into the holding company, Kaleyra S.p.A.. As a result of the merger, Bandyer ceased to exist as a separate legal entity and all its assets and liabilities have been incorporated under Kaleyra S.p.A. effective January 13, 2022.

Reverse Stock Split

On November 7, 2022, Kaleyra received a written notice (the “Price Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing criteria set forth in Section 802.01C of the NYSE’s Listed Company Manual, as the average closing share price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period. Within ten business days of receipt of the Price Notice, the Company responded to the NYSE with respect to its intent to cure the deficiency and provided available alternatives, including, but not limited to, a reverse stock split, subject to shareholder approval, to regain compliance.

On February 14, 2023, Kaleyra held a special meeting of stockholders (the “Special Meeting”) to approve an amendment to the Company’s Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split (the “Reverse Stock Split”).

On March 6, 2023, the Company announced that, following shareholder approval at the Special Meeting of the stockholders held on February 14, 2023, the Company’s Board of Directors approved a 1-for-3.5 Reverse Stock Split of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share, effective as of 12:01 a.m. Eastern Time on March 9, 2023. Beginning with the opening of trading on March 9, 2023, Kaleyra’s common stock began trading on the New York Stock Exchange on a split-adjusted basis under new CUSIP number 483379202 and continued to trade under the symbol “KLR”.

On April 3, 2023, Kaleyra received written confirmation from the NYSE that the Company has regained compliance with the minimum share price continued listing criteria set forth in Section 802.01C of the NYSE’s Listed Company Manual, as the Company's common stock had a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the consecutive 30 trading-day period ended March 31, 2023. Refer to Note 21 - Subsequent Events for more information.

All share, restricted stock unit, and per share information throughout the Company's condensed consolidated financial statements has been retrospectively adjusted to reflect this Reverse Stock Split in accordance with SEC Staff Accounting Bulletins Topic 4.C, Equity Accounts, Change in Capital Structure (ASC 505-10-S99-4).

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company are unaudited, and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, this interim quarterly financial

7


 

report does not include all disclosures required by US GAAP. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, considered necessary to present fairly the financial position, results of operations and cash flows of the Company and its consolidated subsidiaries for all periods presented. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected in the future or for the full fiscal year. It is recommended that these condensed consolidated financial statements be read in conjunction with the Company’s consolidated financial statements and the notes thereto included in its 2022 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 16, 2023. In January 2023, Kaleyra ceased to be an emerging growth company upon the end of fiscal year 2022, following the fifth anniversary of the IPO.

 

Substantial Doubt in Going Concern

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

On November 7, 2022, Kaleyra received a written notice (the “Price Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing criteria set forth in Section 802.01C of the NYSE’s Listed Company Manual, as the average closing share price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period. Within ten business days of receipt of the Price Notice, the Company responded to the NYSE with respect to its intent to cure the deficiency and provided available alternatives, including, but not limited to, a reverse stock split, subject to shareholder approval, to regain compliance.